SEP 14, 2017 7:30 AM PDT

Keynote Presentation: A Mechanistic Approach to Overcoming Antibacterial Drug Resistance

Speaker

Abstract

Quinolones are one the most commonly prescribed classes of antibacterials in the world and are used to treat a broad variety of Gram-negative and Gram-positive bacterial infections in humans. However, because of the wide use (and overuse) of these drugs, the number of quinolone resistant bacterial strains has been growing steadily since the 1990s. As is the case with other antibacterial agents, the rise in quinolone resistance threatens the clinical utility of this important drug class. 

Quinolones target the bacterial type II topoisomerases, gyrase and topoisomerase IV. These enzymes regulate DNA under- and over-winding and remove knots and tangles from the genome. Gyrase and topoisomerase IV create transient double-stranded breaks in the genetic material in order to carry out their essential cellular functions. Quinolones take advantage of this enzyme-mediated DNA cleavage activity and kill cells by converting gyrase and topoisomerase IV, into toxic “nucleases” that fragment the bacterial chromosome.

Quinolone resistance is most often associated with mutations at two highly conserved amino acid residues (a serine and an acidic residue) in gyrase and/or topoisomerase IV. Recent structural and biochemical studies have determined how these two residues facilitate drug-enzyme interactions. Quinolones contain a keto acid group that chelates a non-catalytic Mg2+ ion, which in turn is coordinated by four water molecules. Two of these water molecules are situated close enough to the serine and acidic residue to form hydrogen bonds. For clinically relevant quinolones, this “water-metal ion bridge” serves as the primary interaction between the drug and the bacterial type II topoisomerases.

Dr. Osheroff’s talk will provide background on DNA topology and type II topoisomerases. It will go on to describe experiments that led to the discovery of the water-metal ion bridge and defined its role in mediating quinolone-enzyme interactions. The talk will describe how this knowledge has been used to design novel quinolones and quinolone-based drugs that overcome resistance. Finally, it will discuss recent experiments with novel naphthyridone-based drugs that alter gyrase-mediated DNA cleavage by a unique mechanism and retain their activity against quinolone-resistant mutant enzymes.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
SEP 14, 2017 7:30 AM PDT

Keynote Presentation: A Mechanistic Approach to Overcoming Antibacterial Drug Resistance


Specialty

Research And Development

Toxicology

Pathology

Clinical Chemistry

Earth Science

University

Staphylococcus (Staph Infection)

Pharmacology

Immunology

Biochemistry

Research

Infection

Radiology

Microbiology

Cell Culture

Geography

North America33%

Asia33%

Registration Source

Website Visitors100%

Job Title

Research Scientist50%

Medical Laboratory Technician50%

Organization

Manufacturer - Other33%

Research Institute33%


Show Resources
Loading Comments...
Show Resources